Functional alterations of Lin−CD34+CD38+ cells in chronic myelomonocytic leukemia and on progression to acute leukemia

Passegue, 2003, Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?, Proc Natl Acad Sci USA, 100, 11842, 10.1073/pnas.2034201100 Eisterer, 2005, Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease, Leukemia, 19, 435, 10.1038/sj.leu.2403649 Bennett, 2003, The myelodysplastic/myeloproliferative disorders: the interface, Hematol Oncol Clin North Am, 17, 1095, 10.1016/S0889-8588(03)00086-8 Janssen, 1989, Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin, Blood, 73, 248, 10.1182/blood.V73.1.248.248 Ma, 2004, Circulating myeloid and lymphoid precursor dendritic cells are clonally involved in myelodysplastic syndromes, Leukemia, 18, 1451, 10.1038/sj.leu.2403430 Fenaux, 1988, Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases, J Clin Oncol, 6, 1417, 10.1200/JCO.1988.6.9.1417 Onida, 2002, Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients, Blood, 99, 840, 10.1182/blood.V99.3.840 Goasguen, 1990, Prognostic factors of myelodysplastic syndromes—a simplified 3-D scoring system, Leuk Res, 14, 255, 10.1016/0145-2126(90)90133-T Germing, 2004, Risk assessment in chronic myelomonocytic leukemia (CMML), Leuk Lymphoma, 45, 1311, 10.1080/1042819042000207271 Germing, 1999, Clinical course, morphology and prognosis of chronic myelomonocytic leukemia, Med Klin (Munich), 94, 467, 10.1007/BF03044937 Invernizzi, 2006, Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia, Eur J Haematol, 76, 494, 10.1111/j.0902-4441.2006.t01-1-EJH2588.x Lin, 2002, Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome, Leuk Res, 26, 551, 10.1016/S0145-2126(01)00170-9 Flores-Figueroa, 1999, Hematopoietic progenitor cells from patients with myelodysplastic syndromes: in vitro colony growth and long-term proliferation, Leuk Res, 23, 385, 10.1016/S0145-2126(98)00176-3 Maynadie, 2002, Immunophenotypic clustering of myelodysplastic syndromes, Blood, 100, 2349, 10.1182/blood-2002-01-0230 Vuckovic, 1999, Dendritic cells in chronic myelomonocytic leukaemia, Br J Haematol, 105, 974, 10.1046/j.1365-2141.1999.01431.x Greenberg, 1997, International scoring system for evaluating prognosis in myelodysplastic syndromes, Blood, 89, 2079, 10.1182/blood.V89.6.2079 Costello, 2000, Human acute myeloid leukemia CD34+/CD38− progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities, Cancer Res, 60, 4403 Jamieson, 2004, Granulocyte–macrophage progenitors as candidate leukemic stem cells in blast-crisis CML, N Engl J Med, 351, 657, 10.1056/NEJMoa040258 Manz, 2002, Prospective isolation of human clonogenic common myeloid progenitors, Proc Natl Acad Sci USA, 99, 11872, 10.1073/pnas.172384399 Martinez-Jaramillo, 2007, In vitro functional alterations in the hematopoietic system of adult patients with acute lymphoblastic leukemia, Leuk Res, 31, 83, 10.1016/j.leukres.2006.05.001 Kaleem, 2003, Flow cytometric analysis of acute leukemias diagnostic utility and critical analysis of data, Arch Pathol Lab Med, 127, 42, 10.5858/2003-127-42-FCAOA van Rhenen, 2005, High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival, Clin Cancer Res, 11, 6520, 10.1158/1078-0432.CCR-05-0468 Feller, 2003, High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome, Leukemia, 17, 68, 10.1038/sj.leu.2402781 Cheshier, 1999, In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells, Proc Natl Acad Sci USA, 96, 3120, 10.1073/pnas.96.6.3120 Broxmeyer, 2007, SDF-1/CXCL12 enhances in vitro replating capacity of murine and human multipotential and macrophage progenitor cells, Stem Cells Dev, 16, 589, 10.1089/scd.2007.0044 Ogawa, 2002, Changing phenotypes of hematopoietic stem cells, Exp Hematol, 30, 3, 10.1016/S0301-472X(01)00770-6 Lapidot, 1994, A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature, 367, 645, 10.1038/367645a0 Everson, 1989, Interleukin-6 and granulocyte–macrophage colony-stimulating factor are candidate growth factors for chronic myelomonocytic leukemia cells, Blood, 74, 1472, 10.1182/blood.V74.5.1472.1472 Sagaster, 2004, High spontaneous colony growth in chronic myelomonocytic leukemia correlates with increased disease activity and is a novel prognostic factor for predicting short survival, Ann Hematol, 83, 9, 10.1007/s00277-003-0743-9